Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1395745 | 0.98 | NAAA (0.52) | LMNATSHRTDP1NAAATP53 | |
| SCHEMBL27893206 | 0.98 | NAAA (0.52) | LMNATSHRTDP1NAAATP53 | |
| SCHEMBL27811461 | 0.98 | NAAA (0.52) | LMNATSHRTDP1NAAATP53 | |
| SCHEMBL5662533 | 0.98 | NAAA (0.52) | LMNATSHRTDP1NAAATP53 | |
| SCHEMBL28495462 | 0.97 | NAAA (0.51) | LMNATSHRTDP1NAAATP53 | |
| SCHEMBL28693859 | 0.97 | NAAA (0.51) | LMNATSHRTDP1NAAATP53 | |
| SCHEMBL28237215 | 0.97 | NAAA (0.51) | LMNATSHRTDP1NAAATP53 | |
| SCHEMBL11047101 | 0.97 | NAAA (0.51) | LMNATSHRTDP1NAAATP53 | |
| SCHEMBL28237089 | 0.97 | NAAA (0.51) | LMNATSHRTDP1NAAATP53 | |
| SCHEMBL239011 | 0.95 | LMNA (0.52) | LMNATSHRTDP1NAAATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102188331-B | Hair or head skin cosmetics composite | 株式会社太平洋 | 2016-08-31 | — | — | CN | disclosed |
| EP-1578757-B1 | FLUOROGENIC ENZYME SUBSTRATES AND METHODS OF PREPARATION | JANSSEN INFECTIOUS DISEASES BVBA (BE) | 2014-10-22 | — | — | EP | disclosed |
| CN-102188331-A | Hair or head skin cosmetics composite | TAIHEIYOU CO LTD | 2011-09-21 | — | — | CN | disclosed |
| US-7863428-B2 | Fluorogenic enzyme substrates and methods of preparation | TIBOTEC BVBA (BE) | 2011-01-04 | — | — | US | disclosed |
| CN-101549157-A | Acidic drug for curing toothache within one second | DEYONG FU (CN) | 2009-10-07 | — | — | CN | disclosed |
| US-20070037234-A1 | fluorophores containing 2-(3H-4-oxo-6-n-pentyl-2-quinazolinyl)-4-n-pentylphenyl phosphate; hydrolases; improved cell permeability; photostability | TIBOTEC BVBA (BE) | 2007-02-15 | — | — | US | disclosed |
| CN-1226271-C | Synthesis method of barascamphor salicylatel isobaras camphor salicylate and its derivative | CHANGCHUN APPLIED CHEMISTRY (CN) | 2005-11-09 | — | — | CN | disclosed |
| US-6909012-B2 | Diflunisal esters and related compounds | UNIVERSITY OF QUEENSLAND (AU) | 2005-06-21 | — | — | US | disclosed |
| US-20030220497-A1 | Novel diflunisal esters and related compounds | THE UNIVERSITY OF QUEENSLAND | 2003-11-27 | — | — | US | disclosed |
| US-6593365-B1 | Method for treating and/or controlling thrombosis in a mammal, comprising administering to a mammal in need thereof an effective dosage of a compound having the formula: | THE UNIVERSITY OF QUEENSLAND (AU) | 2003-07-15 | — | — | US | disclosed |
| CN-1410414-A | Synthesis method of barascamphor salicylatel isobaras camphor salicylate and its derivative | CHANGCHUN APPLIED CHEMISTRY (CN) | 2003-04-16 | — | — | CN | disclosed |
| CN-1232672-A | Compound arthritis curing capsule | LIU ZEHUA (CN) | 1999-10-27 | — | — | CN | disclosed |
| WO-1998046234-A1 | NOVEL DIFLUNISAL ESTERS AND RELATED COMPOUNDS | THE UNIVERSITY OF QUEENSLAND (AU) | 1998-10-22 | — | — | WO | disclosed |
| CN-1145582-A | Low pH, hydrolytically stable, cosmetic compsn. containing acidic actives | PROCTER & GAMBLE (US) | 1997-03-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037234-A1 | fluorophores containing 2-(3H-4-oxo-6-n-pentyl-2-quinazolinyl)-4-n-pentylphenyl phosphate; hydrolases; improved cell permeability; photostability | DNPEP, HEXD, NPEPPS | LMNA 2068/4885TSHR 4544/4885TDP1 590/4885 |
| US-20030220497-A1 | Novel diflunisal esters and related compounds | HPGDS, ALOX12, ALOX15 | LMNA 3910/4885TSHR 3834/4885TDP1 3141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.